Israel Englander’s Ginkgo Bioworks DNA Stock Holding History

Israel Englander’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-21,250	Closed	-$1.54M	–	6173
2023 Q3	$1.54M	Buy	+21,250	New	+$1.7M	﹤0.01%	3815
2023 Q2	–	Sell	-12,500	Closed	-$665K	–	6199
2023 Q1	$665K	Hold	12,500	–	–	﹤0.01%	4422
2022 Q4	$845K	Sell	12,500 -10,500	-46%	-$966K	﹤0.01%	4327
2022 Q3	$2.87M	Buy	+23,000	New	+$2.74M	﹤0.01%	3434
2022 Q2	–	Sell	-10,000	Closed	-$1.61M	–	7071
2022 Q1	$1.61M	Buy	10,000 +2,500	+33%	+$487K	﹤0.01%	4073
2021 Q4	$2.49M	Buy	+7,500	New	+$3.56M	﹤0.01%	3563

Other funds holding DNA

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACG

Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Israel Englander's DNA Position: Q2 2026 in Review

Israel Englander increased its Ginkgo Bioworks (DNA) stake by 31% in Q2 2026, buying an estimated $1.26M and bringing the position to 638,676 shares worth $6.33M. The position accounts for ﹤0.01% of the portfolio, ranked #2769.

Israel Englander first reported a position in DNA in Q3 2021 and has held it in 18 quarters since. The position peaked at $17.5M in Q3 2021. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

Israel Englander held 638,676 shares of Ginkgo Bioworks worth $6.33M as of Q2 2026.
Israel Englander bought 150,719 Ginkgo Bioworks shares in Q2 2026, an estimated $1.26M.
Ginkgo Bioworks made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2769 holding.
Israel Englander first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 18 quarters since.
Israel Englander's Ginkgo Bioworks position peaked at $17.5M in Q3 2021.
184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.